chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 32.0
Sex: F
Vaccine: COVID19-2
Symptoms: Burning sensation, Herpes zoster, Hypoaesthesia, Pruritus, Rash
Clinical narrative: It started under my left breast with a numbness, a rash started in the same spot on Sunday and I went to urgent care where I  was diagnosed with Shingles, over the next few weeks it wrapped around my left side to my back it was burning and itchy feeling that lasted a bout a week but two weeks tor get resolved.
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Patient was given the COVID 19 Bivalent Booster past the Beyond Use Date. The BUD date was 01/13/2023.  The patient received the vaccine on 01/16/2023.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Confusional state, Death, Dyspnoea
Clinical narrative: 3RD DOSE MODERNA COVID GIVEN 11/4/21, LOT #045C21A; 4TH DOSE MODERNA COVID GIVEN 5/20/22, LOT #002M21A; pt to ED with seizure-like activity; positive for COVID; chest xray showed right sided lobe pneumonia; O2 supplementation; CCU; hypotensive; difficulty breathing; pt's condition worsened; increase in confusion; on vasopressors; comfort care measures; pt passed away in the hospital
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: General physical health deterioration, Hypotension, Intensive care, Pneumonia, SARS-CoV-2 test positive
Clinical narrative: 3RD DOSE MODERNA COVID GIVEN 11/4/21, LOT #045C21A; 4TH DOSE MODERNA COVID GIVEN 5/20/22, LOT #002M21A; pt to ED with seizure-like activity; positive for COVID; chest xray showed right sided lobe pneumonia; O2 supplementation; CCU; hypotensive; difficulty breathing; pt's condition worsened; increase in confusion; on vasopressors; comfort care measures; pt passed away in the hospital
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Seizure like phenomena
Clinical narrative: 3RD DOSE MODERNA COVID GIVEN 11/4/21, LOT #045C21A; 4TH DOSE MODERNA COVID GIVEN 5/20/22, LOT #002M21A; pt to ED with seizure-like activity; positive for COVID; chest xray showed right sided lobe pneumonia; O2 supplementation; CCU; hypotensive; difficulty breathing; pt's condition worsened; increase in confusion; on vasopressors; comfort care measures; pt passed away in the hospital
Age: 63.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Pain in extremity
Clinical narrative: Pt states she has soreness in both arms since she received the vaccinations.  Her right arm constantly hurts and her left arm has pain that comes and goes.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with 2 boosters
Age: 84.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Patient was given the COVID 19 Bivalent Booster past the Beyond Use Date. The BUD date was 01/13/2023.  The patient received the vaccine on 01/17/2023.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Bronchiolitis, COVID-19, COVID-19 pneumonia, Computerised tomogram neck, Computerised tomogram thorax abnormal
Clinical narrative: Patient is a 75 years Old male patient of, DO with history of AML, RUE DVT, recent COVID diagnosis on 12/28 presented to Hospital with progressive shortness of breath and feeling of throat swelling,admitted with Acute COVID-19 pneumonia,Suspected HAP And Acute Laryngitis/pharyngitis.   CT chest Interval development of sequela of infectious/inflammatory bronchiolitis involving superior segments of both lower lobes and basilar segments of the right lower lobe.  Bronchopneumonia involving basilar segments of the left lower lobe now identified as well. CT Soft tissue Neck;Mild mucosal thickening of the supraglottic larynx, which may represent laryngitis.  No fluid collection or discrete mass.  No foreign body Echocardiogram;Left ventricular systolic function is hyperdynamic with an estimated ejection fraction of >70%. Patient responded to treatment intravenous Decadron, cefepime and supplemental oxygen.  Patient was successfully weaned off supplemental oxygen. However hospital course complicated by progressively worsening white cell counts, differentials 11% blasts.  Case was discussed with University hematologist who recommended that patient be transferred to facility, and initiation of hydroxyurea 2 g every 8 hourly, with labs. Hematology was consulted to assist with orders of hydroxyurea per policy.   Discharge Diagnoses: Acute COVID-19 pneumonia. Suspected HAP Acute Laryngitis,pharyngitis.   AML. RUE DVT,
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Differential white blood cell count, Dyspnoea, Echocardiogram abnormal, Ejection fraction normal, Hyperdynamic left ventricle
Clinical narrative: Patient is a 75 years Old male patient of, DO with history of AML, RUE DVT, recent COVID diagnosis on 12/28 presented to Hospital with progressive shortness of breath and feeling of throat swelling,admitted with Acute COVID-19 pneumonia,Suspected HAP And Acute Laryngitis/pharyngitis.   CT chest Interval development of sequela of infectious/inflammatory bronchiolitis involving superior segments of both lower lobes and basilar segments of the right lower lobe.  Bronchopneumonia involving basilar segments of the left lower lobe now identified as well. CT Soft tissue Neck;Mild mucosal thickening of the supraglottic larynx, which may represent laryngitis.  No fluid collection or discrete mass.  No foreign body Echocardiogram;Left ventricular systolic function is hyperdynamic with an estimated ejection fraction of >70%. Patient responded to treatment intravenous Decadron, cefepime and supplemental oxygen.  Patient was successfully weaned off supplemental oxygen. However hospital course complicated by progressively worsening white cell counts, differentials 11% blasts.  Case was discussed with University hematologist who recommended that patient be transferred to facility, and initiation of hydroxyurea 2 g every 8 hourly, with labs. Hematology was consulted to assist with orders of hydroxyurea per policy.   Discharge Diagnoses: Acute COVID-19 pneumonia. Suspected HAP Acute Laryngitis,pharyngitis.   AML. RUE DVT,
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Laryngitis, Mucosal hypertrophy, Pharyngeal swelling, Pharyngitis, Pneumonia
Clinical narrative: Patient is a 75 years Old male patient of, DO with history of AML, RUE DVT, recent COVID diagnosis on 12/28 presented to Hospital with progressive shortness of breath and feeling of throat swelling,admitted with Acute COVID-19 pneumonia,Suspected HAP And Acute Laryngitis/pharyngitis.   CT chest Interval development of sequela of infectious/inflammatory bronchiolitis involving superior segments of both lower lobes and basilar segments of the right lower lobe.  Bronchopneumonia involving basilar segments of the left lower lobe now identified as well. CT Soft tissue Neck;Mild mucosal thickening of the supraglottic larynx, which may represent laryngitis.  No fluid collection or discrete mass.  No foreign body Echocardiogram;Left ventricular systolic function is hyperdynamic with an estimated ejection fraction of >70%. Patient responded to treatment intravenous Decadron, cefepime and supplemental oxygen.  Patient was successfully weaned off supplemental oxygen. However hospital course complicated by progressively worsening white cell counts, differentials 11% blasts.  Case was discussed with University hematologist who recommended that patient be transferred to facility, and initiation of hydroxyurea 2 g every 8 hourly, with labs. Hematology was consulted to assist with orders of hydroxyurea per policy.   Discharge Diagnoses: Acute COVID-19 pneumonia. Suspected HAP Acute Laryngitis,pharyngitis.   AML. RUE DVT,
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count abnormal
Clinical narrative: Patient is a 75 years Old male patient of, DO with history of AML, RUE DVT, recent COVID diagnosis on 12/28 presented to Hospital with progressive shortness of breath and feeling of throat swelling,admitted with Acute COVID-19 pneumonia,Suspected HAP And Acute Laryngitis/pharyngitis.   CT chest Interval development of sequela of infectious/inflammatory bronchiolitis involving superior segments of both lower lobes and basilar segments of the right lower lobe.  Bronchopneumonia involving basilar segments of the left lower lobe now identified as well. CT Soft tissue Neck;Mild mucosal thickening of the supraglottic larynx, which may represent laryngitis.  No fluid collection or discrete mass.  No foreign body Echocardiogram;Left ventricular systolic function is hyperdynamic with an estimated ejection fraction of >70%. Patient responded to treatment intravenous Decadron, cefepime and supplemental oxygen.  Patient was successfully weaned off supplemental oxygen. However hospital course complicated by progressively worsening white cell counts, differentials 11% blasts.  Case was discussed with University hematologist who recommended that patient be transferred to facility, and initiation of hydroxyurea 2 g every 8 hourly, with labs. Hematology was consulted to assist with orders of hydroxyurea per policy.   Discharge Diagnoses: Acute COVID-19 pneumonia. Suspected HAP Acute Laryngitis,pharyngitis.   AML. RUE DVT,
Age: 81.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Patient was given the COVID 19 Bivalent Booster past the Beyond Use Date. The BUD date was 01/13/2023.  The patient received the vaccine on 01/17/2023.
Age: 74.0
Sex: F
Vaccine: PPV
Symptoms: Dizziness, Pruritus, Visual impairment
Clinical narrative: She got her vaccine, her vision is already blurred really bad, and she has to eat several things, cannot eat carbs, eats protein, fruits and vegetables.  She was loosing the light in her eyes which is what happens when she eats breads, crackers, etc.  The darkness started coming in and she was bit confused with this and felt slightly dizzy.  She was thinking about what she ate, and could not figure out what happened and a candy bar will do this, but she did not eat anything.  Then she started having itching in her skin like she was on fire.  She got into a tub of cool water to help her soothe herself.  She did not have any rash, itching in her private areas, her head, her entire body and also in her mouth and lips.  Her eyes were itching, her nose was itching, her ears.  She had some calamine lotion that she put on, and that did nothing.  When she tried herself off from the cool bath she was still itching, and had no sleep for 2 days.  She did not call her doctor and cannot take Benadryl, and had to suffer itself out and deal with it.  She also put hot towels across her skin and also cold ones.  It has eventually subsided and it took about 3-4 days for these symptoms to subside.  She has an appointment to see her PCP tomorrow as she already had an appointment scheduled.  She will never get another one of these vaccines.  She did not have any issues with itching prior to the vaccine.   She does still have some itching, but has improved greatly.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated
Age: 43.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient came in for a covid vaccine appointment, writer administered the moderna bivalent booster to the patient, patient noted to not have any previous covid vaccines done.
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dysgraphia, Lacunar stroke, Magnetic resonance imaging head abnormal, Mental status changes, Reading disorder
Clinical narrative: Patient experienced altered mental status within hours of the vaccination - could not write sentences or comprehend what he was reading; symptoms lasted for four days; confirmed lacunar stroke on MRI
Age: 89.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Patient was given the COVID 19 Bivalent Booster past the Beyond Use Date. The BUD date was 01/13/2023.  The patient received the vaccine on 01/17/2023.
Age: 0.83
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Pyrexia, SARS-CoV-2 test positive, Skin discolouration
Clinical narrative: She did not have an adverse reaction to the vaccine. She tested positive for COVID-19 on 12/02/2022. No symptoms prior but she woke up with a high fever. Her hands and feet turned purple, and we went to the emergency room. They gave her Tylenol but she threw that up. We were sent home after observation as her hands and feet returned to normal color.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with 1 booster
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash erythematous, Rash papular, Rash pruritic
Clinical narrative: Red, swollen, itchy, rash. Took pictures. Started two days after injection. Lasted for about seven days. Also had the pneumococcal vaccine in the same arm.  When I went for the second injection they thought it might have been because I had two shots in the same arm. This time I only had the one in the right arm on February 4th, 2023, two days later, a rash has started.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Akinesia, Atrial fibrillation, Autonomic nervous system imbalance, COVID-19, Computerised tomogram spine
Clinical narrative: Clinical Summary Patient is a 75 y.o. male with a history of parkinsons, HTN who tested positive for COVID 12/29/22 as outpatient and was about to start paxlovid but was found down 12/30/22 and presented to hospital 12/30/2022 for further evaluation. Consulted by trauma for medical management and then assumed care. Hospital course complicated by sinus pause 1/3/2022.    1. Vertebral fractures: Age indeterminate on CT C spine and CT CAP on admit. Mild T3 and T12 fractures which appear new since CTA PE 10/5/2022. Also noted subacute mild L2 fracture with chronic L1 fracture. Unable to get MRI imaging. Neurosurgery followed, recommended conservative care.  PT OT recommended SNF. 2. COVID 19: Vaccinated. Symptom onset around 12/27-12/28, tested positive 12/29/22. S/p   Paxlovid. Was on 2L O2 but weaned to room air 1/3/2023.  3. Acute metabolic encephalopathy: sec to acute COVID infection, dehydration and missing on parkinson's meds. Resumed sinemet and amantadine, improved.  4. Paroxsymal Atrial Fib with RVR/ sinus pause:Noted 12/30/22 night- EP initially had patient on Cardizem and flecainide, but both discontinued given sinus pause on tele 1/3/2022. Not on AC due to fall risk - family refusal.  Outpatient heart monitor.  Cardiology follow-up 5. Parkinson's Disease: advanced, on amantadine and sinemet. Continued.  6. Akinesia: with increased muscle rigidity- suspect related to not taking parkinson meds x 48h prior to admission, improved with resumption of Parkinson's meds and trial of Valium. Continued valium taper until 1/5/2023.  7. HTN: On valsartan/hydrochlorothiazide amlodipine and metoprolol at home?held. Reported that he gets dizzy if drops below 140. Likley due to autonomic dysfunction due to parkinsons.  Liberal BP goal. 150-160 systolic esp if dizzy and orthostatic.  Can be restarted as outpatient if needed. 8. Neuropathy: Continued home gabapentin. Dose adjusted  9. Dysphagia: Likely due to Parkinson.  Contributing to weight loss? 1/3/2022 with modified diet.  If worsen may need outpatient EGD.  Speech followed. 10. Code status: Full code?
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Dehydration, Dysphagia, Lumbar vertebral fracture, Metabolic encephalopathy, Muscle rigidity
Clinical narrative: Clinical Summary Patient is a 75 y.o. male with a history of parkinsons, HTN who tested positive for COVID 12/29/22 as outpatient and was about to start paxlovid but was found down 12/30/22 and presented to hospital 12/30/2022 for further evaluation. Consulted by trauma for medical management and then assumed care. Hospital course complicated by sinus pause 1/3/2022.    1. Vertebral fractures: Age indeterminate on CT C spine and CT CAP on admit. Mild T3 and T12 fractures which appear new since CTA PE 10/5/2022. Also noted subacute mild L2 fracture with chronic L1 fracture. Unable to get MRI imaging. Neurosurgery followed, recommended conservative care.  PT OT recommended SNF. 2. COVID 19: Vaccinated. Symptom onset around 12/27-12/28, tested positive 12/29/22. S/p   Paxlovid. Was on 2L O2 but weaned to room air 1/3/2023.  3. Acute metabolic encephalopathy: sec to acute COVID infection, dehydration and missing on parkinson's meds. Resumed sinemet and amantadine, improved.  4. Paroxsymal Atrial Fib with RVR/ sinus pause:Noted 12/30/22 night- EP initially had patient on Cardizem and flecainide, but both discontinued given sinus pause on tele 1/3/2022. Not on AC due to fall risk - family refusal.  Outpatient heart monitor.  Cardiology follow-up 5. Parkinson's Disease: advanced, on amantadine and sinemet. Continued.  6. Akinesia: with increased muscle rigidity- suspect related to not taking parkinson meds x 48h prior to admission, improved with resumption of Parkinson's meds and trial of Valium. Continued valium taper until 1/5/2023.  7. HTN: On valsartan/hydrochlorothiazide amlodipine and metoprolol at home?held. Reported that he gets dizzy if drops below 140. Likley due to autonomic dysfunction due to parkinsons.  Liberal BP goal. 150-160 systolic esp if dizzy and orthostatic.  Can be restarted as outpatient if needed. 8. Neuropathy: Continued home gabapentin. Dose adjusted  9. Dysphagia: Likely due to Parkinson.  Contributing to weight loss? 1/3/2022 with modified diet.  If worsen may need outpatient EGD.  Speech followed. 10. Code status: Full code?
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sinus arrest, Thoracic vertebral fracture, Weight decreased
Clinical narrative: Clinical Summary Patient is a 75 y.o. male with a history of parkinsons, HTN who tested positive for COVID 12/29/22 as outpatient and was about to start paxlovid but was found down 12/30/22 and presented to hospital 12/30/2022 for further evaluation. Consulted by trauma for medical management and then assumed care. Hospital course complicated by sinus pause 1/3/2022.    1. Vertebral fractures: Age indeterminate on CT C spine and CT CAP on admit. Mild T3 and T12 fractures which appear new since CTA PE 10/5/2022. Also noted subacute mild L2 fracture with chronic L1 fracture. Unable to get MRI imaging. Neurosurgery followed, recommended conservative care.  PT OT recommended SNF. 2. COVID 19: Vaccinated. Symptom onset around 12/27-12/28, tested positive 12/29/22. S/p   Paxlovid. Was on 2L O2 but weaned to room air 1/3/2023.  3. Acute metabolic encephalopathy: sec to acute COVID infection, dehydration and missing on parkinson's meds. Resumed sinemet and amantadine, improved.  4. Paroxsymal Atrial Fib with RVR/ sinus pause:Noted 12/30/22 night- EP initially had patient on Cardizem and flecainide, but both discontinued given sinus pause on tele 1/3/2022. Not on AC due to fall risk - family refusal.  Outpatient heart monitor.  Cardiology follow-up 5. Parkinson's Disease: advanced, on amantadine and sinemet. Continued.  6. Akinesia: with increased muscle rigidity- suspect related to not taking parkinson meds x 48h prior to admission, improved with resumption of Parkinson's meds and trial of Valium. Continued valium taper until 1/5/2023.  7. HTN: On valsartan/hydrochlorothiazide amlodipine and metoprolol at home?held. Reported that he gets dizzy if drops below 140. Likley due to autonomic dysfunction due to parkinsons.  Liberal BP goal. 150-160 systolic esp if dizzy and orthostatic.  Can be restarted as outpatient if needed. 8. Neuropathy: Continued home gabapentin. Dose adjusted  9. Dysphagia: Likely due to Parkinson.  Contributing to weight loss? 1/3/2022 with modified diet.  If worsen may need outpatient EGD.  Speech followed. 10. Code status: Full code?
Age: 61.0
Sex: F
Vaccine: UNK
Symptoms: Dysgeusia, Fatigue, Hot flush
Clinical narrative: Metal taste - on-going  Hot flashes - on-going  (not experiencing prior) Tired - on-going  needing to take a short afternoon nap ( not experiencing prior)
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 RNA, SARS-CoV-2 test positive
Clinical narrative: HOSPITALIZATION RELATED TO COVID-19 FOLLOWING COMPLETION OF PRIMARY COVID VACCINE SERIES
Age: 98.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with 2 boosters
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Angina pectoris, Anticoagulant therapy, Catheterisation cardiac, Chest discomfort, Coronary artery dissection
Clinical narrative: I had jaw pain, chest pressure, and left arm pain one evening. I had been heart pain as well so I called 911 and was taken to the hospital. There, I was put under several exams including cardiac enzyme testing, EKG, echocardiogram, and heart catheterization and was informed I suffered from spontaneous coronary heart dissection, or a heart attack. I spent two nights in coronary care unit. I was given heparin and aspirin as well as PLAVIX. I was prescribed CRESTOR during discharge until my follow-up appointment with my cardiologist. Currently, I'm doing better until my next appointment for better accuracy of diagnosis.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Echocardiogram, Electrocardiogram, Myocardial infarction, Myocardial necrosis marker, Pain in extremity
Clinical narrative: I had jaw pain, chest pressure, and left arm pain one evening. I had been heart pain as well so I called 911 and was taken to the hospital. There, I was put under several exams including cardiac enzyme testing, EKG, echocardiogram, and heart catheterization and was informed I suffered from spontaneous coronary heart dissection, or a heart attack. I spent two nights in coronary care unit. I was given heparin and aspirin as well as PLAVIX. I was prescribed CRESTOR during discharge until my follow-up appointment with my cardiologist. Currently, I'm doing better until my next appointment for better accuracy of diagnosis.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain in jaw
Clinical narrative: I had jaw pain, chest pressure, and left arm pain one evening. I had been heart pain as well so I called 911 and was taken to the hospital. There, I was put under several exams including cardiac enzyme testing, EKG, echocardiogram, and heart catheterization and was informed I suffered from spontaneous coronary heart dissection, or a heart attack. I spent two nights in coronary care unit. I was given heparin and aspirin as well as PLAVIX. I was prescribed CRESTOR during discharge until my follow-up appointment with my cardiologist. Currently, I'm doing better until my next appointment for better accuracy of diagnosis.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Angiogram pulmonary abnormal, Blood creatinine increased, Blood gases abnormal
Clinical narrative: Patient is a 50 y.o. female patient of CNP with a history of Morbid obesity, COPD, Chronic respiratory failure on 3 L oxygen, Hypertension, Hyperlipidemia, GERD, Anemia, Tobacco abuse, presented with cough.   Acute on chronic respiratory failure with hypoxia and hypercapnia Secondary COVID-19 pneumonia, PNA, COPD exacerbation on suspected underlying OSA/OHS, and pulmonary HTN  VBG reveals compensated respiratory acidosis Required HHFNC, now on NC, at home reports she is on 3L 02  Discharged on home 3L 02  IS, pulm hygiene  Pulm followed   COVID-19 pneumonia Date of onset of symptoms: 12/27 Symptoms present on admission: Cough, subjective fever/sweats Date of covid positive test: 12/31/2022 Vaccination status: vaccinated Imaging: Groundglass throughout bilateral lungs with consolidation lower lobes on CTPA Oxygen requirements on admission: HHFNC Medical therapy: remdesivir and steroids,  IV Lasix prn given, will give rx for decadron on discharge  Consultants following: Pulmonology Anticipated special isolation end date: 1/11/2022   Community-acquired pneumonia Covid -19 pneumonia with superimposed bacterial pneumonia  Subjective fever, cough  CT with bilateral ground glass, R trace effusion  Cont  Rocephin and Zithromax Micro unreavling, complete course omnicef on discharge    COPD exacerbation Decadron as above Schedule DuoNeb/PRN albuterol nebs Symbicort and albuterol rx given on discharge    AKI Creatinine 1.07 (9/12/2022) -- > 1.25 on admission Held benazepril, will now resume     Atypical chest pain Likely MSK etiology CTPA motion limited, negative for large central PE Initial troponin 21 setting of AKI EKG NSR, normal PR interval, normal QTC, T wave inversion lead III stable compared to EKG 9/12/2022 Troponin trend flat; no further work-up  Essential hypertension Holding benazepril secondary to AKI Continue amlodipine   Cigarette nicotine dependence Smoking 1ppd  Nicotine patch, PRN nicotine gum Encouraged cessation    Morbid Obesity Body mass index is 45.42 kg/m².
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chest pain, Chronic obstructive pulmonary disease, Condition aggravated, Cough
Clinical narrative: Patient is a 50 y.o. female patient of CNP with a history of Morbid obesity, COPD, Chronic respiratory failure on 3 L oxygen, Hypertension, Hyperlipidemia, GERD, Anemia, Tobacco abuse, presented with cough.   Acute on chronic respiratory failure with hypoxia and hypercapnia Secondary COVID-19 pneumonia, PNA, COPD exacerbation on suspected underlying OSA/OHS, and pulmonary HTN  VBG reveals compensated respiratory acidosis Required HHFNC, now on NC, at home reports she is on 3L 02  Discharged on home 3L 02  IS, pulm hygiene  Pulm followed   COVID-19 pneumonia Date of onset of symptoms: 12/27 Symptoms present on admission: Cough, subjective fever/sweats Date of covid positive test: 12/31/2022 Vaccination status: vaccinated Imaging: Groundglass throughout bilateral lungs with consolidation lower lobes on CTPA Oxygen requirements on admission: HHFNC Medical therapy: remdesivir and steroids,  IV Lasix prn given, will give rx for decadron on discharge  Consultants following: Pulmonology Anticipated special isolation end date: 1/11/2022   Community-acquired pneumonia Covid -19 pneumonia with superimposed bacterial pneumonia  Subjective fever, cough  CT with bilateral ground glass, R trace effusion  Cont  Rocephin and Zithromax Micro unreavling, complete course omnicef on discharge    COPD exacerbation Decadron as above Schedule DuoNeb/PRN albuterol nebs Symbicort and albuterol rx given on discharge    AKI Creatinine 1.07 (9/12/2022) -- > 1.25 on admission Held benazepril, will now resume     Atypical chest pain Likely MSK etiology CTPA motion limited, negative for large central PE Initial troponin 21 setting of AKI EKG NSR, normal PR interval, normal QTC, T wave inversion lead III stable compared to EKG 9/12/2022 Troponin trend flat; no further work-up  Essential hypertension Holding benazepril secondary to AKI Continue amlodipine   Cigarette nicotine dependence Smoking 1ppd  Nicotine patch, PRN nicotine gum Encouraged cessation    Morbid Obesity Body mass index is 45.42 kg/m².
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram normal, Hyperhidrosis, Lung consolidation, Lung opacity, Obstructive sleep apnoea syndrome
Clinical narrative: Patient is a 50 y.o. female patient of CNP with a history of Morbid obesity, COPD, Chronic respiratory failure on 3 L oxygen, Hypertension, Hyperlipidemia, GERD, Anemia, Tobacco abuse, presented with cough.   Acute on chronic respiratory failure with hypoxia and hypercapnia Secondary COVID-19 pneumonia, PNA, COPD exacerbation on suspected underlying OSA/OHS, and pulmonary HTN  VBG reveals compensated respiratory acidosis Required HHFNC, now on NC, at home reports she is on 3L 02  Discharged on home 3L 02  IS, pulm hygiene  Pulm followed   COVID-19 pneumonia Date of onset of symptoms: 12/27 Symptoms present on admission: Cough, subjective fever/sweats Date of covid positive test: 12/31/2022 Vaccination status: vaccinated Imaging: Groundglass throughout bilateral lungs with consolidation lower lobes on CTPA Oxygen requirements on admission: HHFNC Medical therapy: remdesivir and steroids,  IV Lasix prn given, will give rx for decadron on discharge  Consultants following: Pulmonology Anticipated special isolation end date: 1/11/2022   Community-acquired pneumonia Covid -19 pneumonia with superimposed bacterial pneumonia  Subjective fever, cough  CT with bilateral ground glass, R trace effusion  Cont  Rocephin and Zithromax Micro unreavling, complete course omnicef on discharge    COPD exacerbation Decadron as above Schedule DuoNeb/PRN albuterol nebs Symbicort and albuterol rx given on discharge    AKI Creatinine 1.07 (9/12/2022) -- > 1.25 on admission Held benazepril, will now resume     Atypical chest pain Likely MSK etiology CTPA motion limited, negative for large central PE Initial troponin 21 setting of AKI EKG NSR, normal PR interval, normal QTC, T wave inversion lead III stable compared to EKG 9/12/2022 Troponin trend flat; no further work-up  Essential hypertension Holding benazepril secondary to AKI Continue amlodipine   Cigarette nicotine dependence Smoking 1ppd  Nicotine patch, PRN nicotine gum Encouraged cessation    Morbid Obesity Body mass index is 45.42 kg/m².
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pickwickian syndrome, Pleural effusion, Pneumonia, Pneumonia bacterial, Pulmonary hypertension
Clinical narrative: Patient is a 50 y.o. female patient of CNP with a history of Morbid obesity, COPD, Chronic respiratory failure on 3 L oxygen, Hypertension, Hyperlipidemia, GERD, Anemia, Tobacco abuse, presented with cough.   Acute on chronic respiratory failure with hypoxia and hypercapnia Secondary COVID-19 pneumonia, PNA, COPD exacerbation on suspected underlying OSA/OHS, and pulmonary HTN  VBG reveals compensated respiratory acidosis Required HHFNC, now on NC, at home reports she is on 3L 02  Discharged on home 3L 02  IS, pulm hygiene  Pulm followed   COVID-19 pneumonia Date of onset of symptoms: 12/27 Symptoms present on admission: Cough, subjective fever/sweats Date of covid positive test: 12/31/2022 Vaccination status: vaccinated Imaging: Groundglass throughout bilateral lungs with consolidation lower lobes on CTPA Oxygen requirements on admission: HHFNC Medical therapy: remdesivir and steroids,  IV Lasix prn given, will give rx for decadron on discharge  Consultants following: Pulmonology Anticipated special isolation end date: 1/11/2022   Community-acquired pneumonia Covid -19 pneumonia with superimposed bacterial pneumonia  Subjective fever, cough  CT with bilateral ground glass, R trace effusion  Cont  Rocephin and Zithromax Micro unreavling, complete course omnicef on discharge    COPD exacerbation Decadron as above Schedule DuoNeb/PRN albuterol nebs Symbicort and albuterol rx given on discharge    AKI Creatinine 1.07 (9/12/2022) -- > 1.25 on admission Held benazepril, will now resume     Atypical chest pain Likely MSK etiology CTPA motion limited, negative for large central PE Initial troponin 21 setting of AKI EKG NSR, normal PR interval, normal QTC, T wave inversion lead III stable compared to EKG 9/12/2022 Troponin trend flat; no further work-up  Essential hypertension Holding benazepril secondary to AKI Continue amlodipine   Cigarette nicotine dependence Smoking 1ppd  Nicotine patch, PRN nicotine gum Encouraged cessation    Morbid Obesity Body mass index is 45.42 kg/m².
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory acidosis, Respiratory failure, SARS-CoV-2 test positive, Superinfection
Clinical narrative: Patient is a 50 y.o. female patient of CNP with a history of Morbid obesity, COPD, Chronic respiratory failure on 3 L oxygen, Hypertension, Hyperlipidemia, GERD, Anemia, Tobacco abuse, presented with cough.   Acute on chronic respiratory failure with hypoxia and hypercapnia Secondary COVID-19 pneumonia, PNA, COPD exacerbation on suspected underlying OSA/OHS, and pulmonary HTN  VBG reveals compensated respiratory acidosis Required HHFNC, now on NC, at home reports she is on 3L 02  Discharged on home 3L 02  IS, pulm hygiene  Pulm followed   COVID-19 pneumonia Date of onset of symptoms: 12/27 Symptoms present on admission: Cough, subjective fever/sweats Date of covid positive test: 12/31/2022 Vaccination status: vaccinated Imaging: Groundglass throughout bilateral lungs with consolidation lower lobes on CTPA Oxygen requirements on admission: HHFNC Medical therapy: remdesivir and steroids,  IV Lasix prn given, will give rx for decadron on discharge  Consultants following: Pulmonology Anticipated special isolation end date: 1/11/2022   Community-acquired pneumonia Covid -19 pneumonia with superimposed bacterial pneumonia  Subjective fever, cough  CT with bilateral ground glass, R trace effusion  Cont  Rocephin and Zithromax Micro unreavling, complete course omnicef on discharge    COPD exacerbation Decadron as above Schedule DuoNeb/PRN albuterol nebs Symbicort and albuterol rx given on discharge    AKI Creatinine 1.07 (9/12/2022) -- > 1.25 on admission Held benazepril, will now resume     Atypical chest pain Likely MSK etiology CTPA motion limited, negative for large central PE Initial troponin 21 setting of AKI EKG NSR, normal PR interval, normal QTC, T wave inversion lead III stable compared to EKG 9/12/2022 Troponin trend flat; no further work-up  Essential hypertension Holding benazepril secondary to AKI Continue amlodipine   Cigarette nicotine dependence Smoking 1ppd  Nicotine patch, PRN nicotine gum Encouraged cessation    Morbid Obesity Body mass index is 45.42 kg/m².
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin increased
Clinical narrative: Patient is a 50 y.o. female patient of CNP with a history of Morbid obesity, COPD, Chronic respiratory failure on 3 L oxygen, Hypertension, Hyperlipidemia, GERD, Anemia, Tobacco abuse, presented with cough.   Acute on chronic respiratory failure with hypoxia and hypercapnia Secondary COVID-19 pneumonia, PNA, COPD exacerbation on suspected underlying OSA/OHS, and pulmonary HTN  VBG reveals compensated respiratory acidosis Required HHFNC, now on NC, at home reports she is on 3L 02  Discharged on home 3L 02  IS, pulm hygiene  Pulm followed   COVID-19 pneumonia Date of onset of symptoms: 12/27 Symptoms present on admission: Cough, subjective fever/sweats Date of covid positive test: 12/31/2022 Vaccination status: vaccinated Imaging: Groundglass throughout bilateral lungs with consolidation lower lobes on CTPA Oxygen requirements on admission: HHFNC Medical therapy: remdesivir and steroids,  IV Lasix prn given, will give rx for decadron on discharge  Consultants following: Pulmonology Anticipated special isolation end date: 1/11/2022   Community-acquired pneumonia Covid -19 pneumonia with superimposed bacterial pneumonia  Subjective fever, cough  CT with bilateral ground glass, R trace effusion  Cont  Rocephin and Zithromax Micro unreavling, complete course omnicef on discharge    COPD exacerbation Decadron as above Schedule DuoNeb/PRN albuterol nebs Symbicort and albuterol rx given on discharge    AKI Creatinine 1.07 (9/12/2022) -- > 1.25 on admission Held benazepril, will now resume     Atypical chest pain Likely MSK etiology CTPA motion limited, negative for large central PE Initial troponin 21 setting of AKI EKG NSR, normal PR interval, normal QTC, T wave inversion lead III stable compared to EKG 9/12/2022 Troponin trend flat; no further work-up  Essential hypertension Holding benazepril secondary to AKI Continue amlodipine   Cigarette nicotine dependence Smoking 1ppd  Nicotine patch, PRN nicotine gum Encouraged cessation    Morbid Obesity Body mass index is 45.42 kg/m².
Age: 89.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19
Clinical narrative: hospitalized with covid; fully vaccinated with 2 boosters
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Otorrhoea, SARS-CoV-2 test positive, Sinus disorder
Clinical narrative: SOB, ear drainage, and sinus sx on admission. Found COVID positive. Treatment includes oxygen, hydration, and sepsis protocol.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Anaemia, Anxiety, Blood creatinine increased
Clinical narrative: Patient is a 66 y.o. female patient    with history of metastatic lung CA, COVID, GI bleed, who presented to  Hospital with SOB.  While in the ER patient found to have COVID 19 infection and is admitted for further management.   COVID-19 pneumonia Patient was initially hospitalized from 11/21-12/4 for COVID-pneumonia Positive for COVID again on 1/1/2023 Given acute decompensation patient has been started on remdesivir and dexamethasone Was on high flow nasal cannula, now doing well on low-flow nasal cannula Encourage incentive spirometry use and out of bed when possible ID consult.  Chest x-ray reviewed with significant bilateral airspace disease. Patient remains on 4 L nasal cannula   Acute hypoxemic respiratory failure Multifocal pneumonia Severe Sepsis and lactic acidosis 2/2 above CT chest reviewed concerning for multifocal pneumonia On 4 L nasal cannula MRSA swab negative.  Vancomycin discontinued Zosyn discontinued per IDFF Follow sputum and blood cultures. ID following.   AKI-improved Hypokalemia Patient's baseline creatinine is around 0.8, creatinine elevated to 1.5 on admission Initially had improved with IV fluids.   Goal to keep net even or slightly negative.   Anxiety and panic attack disorder: Discussed with psychiatrist, will follow up with patient as outpatient as patient is COVID-positive which I agree is reasonable plan.    Chronic anemia: Likely multifactorial due to chemo and recent GI bleed Recent colonoscopy showed multiple tubular adenoma masses Follow up outpatient as previously planned   Stage IV KRAS+ PDL1 low invasive mucinous adenosarcoma of left lung, metastatic to the contralateral lung with mediastinal and bilateral hilar lymphadenopathy: H/o pneumonitis secondary to IO: Transitioned to Sotarasib in Dec 2022 s/p palliative XRT 800 cGy/fraction on 4/13/2022 and 4 cycles of Carbo/pemetrexed and pembrolizumab. She was receiving maintenance Pemetrexed and Pembrolizumab. Clinic oncology consult
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Blood culture, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Colonoscopy abnormal
Clinical narrative: Patient is a 66 y.o. female patient    with history of metastatic lung CA, COVID, GI bleed, who presented to  Hospital with SOB.  While in the ER patient found to have COVID 19 infection and is admitted for further management.   COVID-19 pneumonia Patient was initially hospitalized from 11/21-12/4 for COVID-pneumonia Positive for COVID again on 1/1/2023 Given acute decompensation patient has been started on remdesivir and dexamethasone Was on high flow nasal cannula, now doing well on low-flow nasal cannula Encourage incentive spirometry use and out of bed when possible ID consult.  Chest x-ray reviewed with significant bilateral airspace disease. Patient remains on 4 L nasal cannula   Acute hypoxemic respiratory failure Multifocal pneumonia Severe Sepsis and lactic acidosis 2/2 above CT chest reviewed concerning for multifocal pneumonia On 4 L nasal cannula MRSA swab negative.  Vancomycin discontinued Zosyn discontinued per IDFF Follow sputum and blood cultures. ID following.   AKI-improved Hypokalemia Patient's baseline creatinine is around 0.8, creatinine elevated to 1.5 on admission Initially had improved with IV fluids.   Goal to keep net even or slightly negative.   Anxiety and panic attack disorder: Discussed with psychiatrist, will follow up with patient as outpatient as patient is COVID-positive which I agree is reasonable plan.    Chronic anemia: Likely multifactorial due to chemo and recent GI bleed Recent colonoscopy showed multiple tubular adenoma masses Follow up outpatient as previously planned   Stage IV KRAS+ PDL1 low invasive mucinous adenosarcoma of left lung, metastatic to the contralateral lung with mediastinal and bilateral hilar lymphadenopathy: H/o pneumonitis secondary to IO: Transitioned to Sotarasib in Dec 2022 s/p palliative XRT 800 cGy/fraction on 4/13/2022 and 4 cycles of Carbo/pemetrexed and pembrolizumab. She was receiving maintenance Pemetrexed and Pembrolizumab. Clinic oncology consult
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Colorectal adenoma, Computerised tomogram thorax abnormal, Dyspnoea, Hilar lymphadenopathy, Hypokalaemia
Clinical narrative: Patient is a 66 y.o. female patient    with history of metastatic lung CA, COVID, GI bleed, who presented to  Hospital with SOB.  While in the ER patient found to have COVID 19 infection and is admitted for further management.   COVID-19 pneumonia Patient was initially hospitalized from 11/21-12/4 for COVID-pneumonia Positive for COVID again on 1/1/2023 Given acute decompensation patient has been started on remdesivir and dexamethasone Was on high flow nasal cannula, now doing well on low-flow nasal cannula Encourage incentive spirometry use and out of bed when possible ID consult.  Chest x-ray reviewed with significant bilateral airspace disease. Patient remains on 4 L nasal cannula   Acute hypoxemic respiratory failure Multifocal pneumonia Severe Sepsis and lactic acidosis 2/2 above CT chest reviewed concerning for multifocal pneumonia On 4 L nasal cannula MRSA swab negative.  Vancomycin discontinued Zosyn discontinued per IDFF Follow sputum and blood cultures. ID following.   AKI-improved Hypokalemia Patient's baseline creatinine is around 0.8, creatinine elevated to 1.5 on admission Initially had improved with IV fluids.   Goal to keep net even or slightly negative.   Anxiety and panic attack disorder: Discussed with psychiatrist, will follow up with patient as outpatient as patient is COVID-positive which I agree is reasonable plan.    Chronic anemia: Likely multifactorial due to chemo and recent GI bleed Recent colonoscopy showed multiple tubular adenoma masses Follow up outpatient as previously planned   Stage IV KRAS+ PDL1 low invasive mucinous adenosarcoma of left lung, metastatic to the contralateral lung with mediastinal and bilateral hilar lymphadenopathy: H/o pneumonitis secondary to IO: Transitioned to Sotarasib in Dec 2022 s/p palliative XRT 800 cGy/fraction on 4/13/2022 and 4 cycles of Carbo/pemetrexed and pembrolizumab. She was receiving maintenance Pemetrexed and Pembrolizumab. Clinic oncology consult
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Lactic acidosis, Lung disorder, Panic attack, Pneumonia, Pneumonitis
Clinical narrative: Patient is a 66 y.o. female patient    with history of metastatic lung CA, COVID, GI bleed, who presented to  Hospital with SOB.  While in the ER patient found to have COVID 19 infection and is admitted for further management.   COVID-19 pneumonia Patient was initially hospitalized from 11/21-12/4 for COVID-pneumonia Positive for COVID again on 1/1/2023 Given acute decompensation patient has been started on remdesivir and dexamethasone Was on high flow nasal cannula, now doing well on low-flow nasal cannula Encourage incentive spirometry use and out of bed when possible ID consult.  Chest x-ray reviewed with significant bilateral airspace disease. Patient remains on 4 L nasal cannula   Acute hypoxemic respiratory failure Multifocal pneumonia Severe Sepsis and lactic acidosis 2/2 above CT chest reviewed concerning for multifocal pneumonia On 4 L nasal cannula MRSA swab negative.  Vancomycin discontinued Zosyn discontinued per IDFF Follow sputum and blood cultures. ID following.   AKI-improved Hypokalemia Patient's baseline creatinine is around 0.8, creatinine elevated to 1.5 on admission Initially had improved with IV fluids.   Goal to keep net even or slightly negative.   Anxiety and panic attack disorder: Discussed with psychiatrist, will follow up with patient as outpatient as patient is COVID-positive which I agree is reasonable plan.    Chronic anemia: Likely multifactorial due to chemo and recent GI bleed Recent colonoscopy showed multiple tubular adenoma masses Follow up outpatient as previously planned   Stage IV KRAS+ PDL1 low invasive mucinous adenosarcoma of left lung, metastatic to the contralateral lung with mediastinal and bilateral hilar lymphadenopathy: H/o pneumonitis secondary to IO: Transitioned to Sotarasib in Dec 2022 s/p palliative XRT 800 cGy/fraction on 4/13/2022 and 4 cycles of Carbo/pemetrexed and pembrolizumab. She was receiving maintenance Pemetrexed and Pembrolizumab. Clinic oncology consult
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Sputum culture, Staphylococcus test negative
Clinical narrative: Patient is a 66 y.o. female patient    with history of metastatic lung CA, COVID, GI bleed, who presented to  Hospital with SOB.  While in the ER patient found to have COVID 19 infection and is admitted for further management.   COVID-19 pneumonia Patient was initially hospitalized from 11/21-12/4 for COVID-pneumonia Positive for COVID again on 1/1/2023 Given acute decompensation patient has been started on remdesivir and dexamethasone Was on high flow nasal cannula, now doing well on low-flow nasal cannula Encourage incentive spirometry use and out of bed when possible ID consult.  Chest x-ray reviewed with significant bilateral airspace disease. Patient remains on 4 L nasal cannula   Acute hypoxemic respiratory failure Multifocal pneumonia Severe Sepsis and lactic acidosis 2/2 above CT chest reviewed concerning for multifocal pneumonia On 4 L nasal cannula MRSA swab negative.  Vancomycin discontinued Zosyn discontinued per IDFF Follow sputum and blood cultures. ID following.   AKI-improved Hypokalemia Patient's baseline creatinine is around 0.8, creatinine elevated to 1.5 on admission Initially had improved with IV fluids.   Goal to keep net even or slightly negative.   Anxiety and panic attack disorder: Discussed with psychiatrist, will follow up with patient as outpatient as patient is COVID-positive which I agree is reasonable plan.    Chronic anemia: Likely multifactorial due to chemo and recent GI bleed Recent colonoscopy showed multiple tubular adenoma masses Follow up outpatient as previously planned   Stage IV KRAS+ PDL1 low invasive mucinous adenosarcoma of left lung, metastatic to the contralateral lung with mediastinal and bilateral hilar lymphadenopathy: H/o pneumonitis secondary to IO: Transitioned to Sotarasib in Dec 2022 s/p palliative XRT 800 cGy/fraction on 4/13/2022 and 4 cycles of Carbo/pemetrexed and pembrolizumab. She was receiving maintenance Pemetrexed and Pembrolizumab. Clinic oncology consult
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, COVID-19, Condition aggravated, Laryngitis, Pyrexia
Clinical narrative: It started out with asthma, it felt like I was breathing in glass. Someone in my office felt the same. I switched to my Trilogy inhaler, It was under control. A few days later I was having more and more symptoms of sinus congestion. Because of medication I am on, I keep taking what I had, and it did not last very long maybe a week. My asthma symptoms lasted a couple of days. I did contract COVID-19 on 12/22/2023. I started out with a laryngitis symptom and had a rust voice. I used a at home COVID-19 test and it said, I was positive. By that afternoon I had a fever the first in 40 years, it was like 99.8 it almost got up to 102 by the next day. I did a telehealth with my General Practitioner and was prescribed a cough syrup and Paxlovid type of medication that started with a "M". It was for 5 days, It really was only three days of symptoms. My fever broke on the third day, and I got a terrible sinus infection after COVID-19. It took me months to get rid of, I got a 10-day antibiotic course and finally it's cleared now.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sinus congestion, Sinusitis
Clinical narrative: It started out with asthma, it felt like I was breathing in glass. Someone in my office felt the same. I switched to my Trilogy inhaler, It was under control. A few days later I was having more and more symptoms of sinus congestion. Because of medication I am on, I keep taking what I had, and it did not last very long maybe a week. My asthma symptoms lasted a couple of days. I did contract COVID-19 on 12/22/2023. I started out with a laryngitis symptom and had a rust voice. I used a at home COVID-19 test and it said, I was positive. By that afternoon I had a fever the first in 40 years, it was like 99.8 it almost got up to 102 by the next day. I did a telehealth with my General Practitioner and was prescribed a cough syrup and Paxlovid type of medication that started with a "M". It was for 5 days, It really was only three days of symptoms. My fever broke on the third day, and I got a terrible sinus infection after COVID-19. It took me months to get rid of, I got a 10-day antibiotic course and finally it's cleared now.